Magnetic resonance imaging of the breast for preoperative evaluation in patients with localized breast cancer
BlueCross Blue Shield Association
Record ID 32004000717
English
Authors' objectives:
This Assessment evaluates the clinical effectiveness of magnetic resonance imaging (MRI) of the breast for preoperative evaluation of patients with localized breast cancer (Stage I or II, T0-1 N0-1 M0).
Authors' recommendations:
Evidence from 6 major randomized trials comparing outcomes of mastectomy versus BCT for early stage breast cancer finds no significant differences in overall or disease-free survival during intermediate or long-term follow-up to 20 years. Rates of locoregional recurrence are no different at intermediate follow-up for mastectomy versus BCT with radiation; however, statistically significant differences in locoregional recurrence emerge during long-term follow-up, favoring mastectomy over BCT with radiation. Nevertheless, it is not clear whether these delayed recurrences relate to unresected multicentric disease at the time of initial surgery and whether the use of MRI for preoperative evaluation to guide mastectomy would reduce these delayed recurrences.
Authors' methods:
Review
Details
Project Status:
Completed
URL for project:
http://www.bcbs.com/blueresources/tec/contact-tec.html
Year Published:
2004
English language abstract:
An English language summary is available
Publication Type:
Not Assigned
Country:
United States
MeSH Terms
- Magnetic Resonance Imaging
- Breast Neoplasms
Contact
Organisation Name:
BlueCross BlueShield Association
Contact Address:
BlueCross BlueShield Association, Technology Evaluation Center, 225 North Michigan Ave, Chicago, Illinois, USA. Tel: 888 832 4321
Contact Name:
tec@bcbsa.com
Contact Email:
tec@bcbsa.com
Copyright:
BlueCross BlueShield Association (BCBS)
This is a bibliographic record of a published health technology assessment from a member of INAHTA or other HTA producer. No evaluation of the quality of this assessment has been made for the HTA database.